Cost Effectiveness Analysis Haloperidol-Chlorpromazine and Haloperidol-Risperidone for Treatment of Schizophrenia Patients at dr. H. Marzoeki Mahdi Hospital Bogor

Authors

  • Fitriani Putri Universitas Pancasila ,
  • Delina Hasan Departemen Farmasi, Fakultas Ilmu Kesehatan UIN Syarif Hidayatullah ,
  • Ahmad Fuad Afdhal Universitas Pancasila ,
  • Lahargo Kembaren Ruang Rawat Inap, Rumah Sakit dr. H. Marzoeki Mahdi Bogor ,

DOI:

https://doi.org/10.35814/jifi.v18i2.899

Keywords:

Schizophrenia, combination antipsychotic, haloperidol, chlorpromazine, risperidone, effective and efficient

Abstract

Schizophrenia is a disease that requires a long treatment time, this will have an impact on drug use and costs in the long term. Therefore it is necessary to find an alternative drug that is eff ective and effi cient by using pharmacoeconomics methods, that is cost-eff ectiveness analysis. The purpose of this study was to determine which of the two combination drugs was eff ective and effi cient for the treatment of schizophrenic patients in hospital Marzoeki Mahdi Bogor. This research method used cross sectional design, the sample size in this study was 90 schizophrenic patients obtained from patient medical records and data collected prospectively from dr. H. Marzoeki Mahdi in 2019. Samples were divided equally into two groups, one group received haloperidol - chlorpromazine and the second group received haloperidol - risperidone. The eff ectiveness parameter used in this study is the GAF (Global Assessment of Functioning) value. The results showed that the combination of haloperidol - risperidone was more eff ective than the combination of haloperidol - risperidone, this was evidenced by an increase in the patients GAF value by 95.5% (43 patients) with an average diff erence between the initial and fi nal GAF values of 6.89, while the combination of haloperidol - chlorpromazine amounted to 93.3% (42 patients) with an average diff erence between the initial and fi nal GAF values of 5.84. The ACER value of haloperidol - chlorpromazine is Rp. 6,587,753 and the ACER value for the haloperidol – risperidone combination is Rp. 6,148,897. In conclusion, the haloperidol - risperidone combination is more cost eff ective (p < 0.05) than the haloperidol - chlorpromazine combination.

References

Downloads

Published

2020-10-28

Issue

Vol. 18 No. 2 (2020): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.